Pharmaceuticals, Biotechnology and Life Sciences
Phase 3, multicenter U.S. clinical trial utilizing Octagam® 10% will start immediately to evaluate if high-dose IVIG can stabilize or…
As the corona virus pandemic makes the conduct of clinical studies very complex and leads to standstill in many places,…
Biodesix, Bio-Rad will launch a blood-based immunoassay-based test that identifies antibodies to SARS-CoV-2, the virus that causes COVID-19.
Covid-19 has caused great interruption to pharmaceutical trials, as most resources have shifted to finding a vaccine and many ongoing trials have been disrupted, according to a report by Wakefield Research, an independent provider of market research and market intelligence.
Moderna said that after two doses all participants evaluated to date across the 25 µg and 100 µg dose cohorts…
SAN DIEGO–(BUSINESS WIRE)–Abcore, Inc., a leader in contract research and development of single domain antibodies announced a panel of functional…
Companies selling personal protective equipment like face masks and gloves seem to be having a hard time getting their products to their target audience, no thanks to the practices of online platforms such as search engines, online stores, and social media networking sites.
GeneMe, a leading biotech company based in Gdańsk, Poland has developed “FRANKD” – a fast, scalable and reliable mouth swab test for COVID-19 that is completed on-premises in on average 13-25 minutes with no laboratory involvement.
CanFite is working on Piclidenoson’s anti-viral, anti-inflammatory, anti-rheumatic properties and excellent safety profile make it a strong candidate for the…
Avacta said that Affimer reagents recently generated for development of a point-of-care COVID-19 antigen saliva test have now also been shown to block the interaction between the virus’ spike protein and ACE2, a receptor on human cells that is key to the virus infection pathway.